Healthcare / Health Information ServicesASX
$0.03
-0.00 (-7.14%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-4.0M · quality 74.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$30M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-12.5%
↓Gross Margin
N/A
•Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
3.21x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-1.2M · FCF $-4.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | $22074.00 | $40038.00 | $101656.00 |
| Net Income | $-1.2M | $-1.2M | $-3.1M | $-12.7M | $-1.5M |
| EBITDA | $-1.1M | $-1.1M | $-2.6M | $-12.3M | $-1.3M |
| EPS | -0.00 | -0.00 | -0.02 | -0.12 | -0.02 |
| Gross Margin | — | — | 99.3% | 97.3% | -67.9% |
| Operating Margin | — | — | -12129.9% | -9086.8% | -2591.6% |
| Net Margin | — | — | -14132.9% | -31759.3% | -1462.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 |
| Current Ratio | 5.45 | 5.45 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.0M | $-4.0M | $-3.2M | $-4.6M | $-3.5M |
| Returns | |||||
| ROE | -12.5% | -12.5% | -49.2% | -178.9% | -9.1% |
| Valuation | |||||
| P/B | 0.87 | 0.87 | 0.56 | 0.58 | 0.93 |
| Growth & Yield | |||||
| Revenue Growth | — | — | -44.9% | -60.6% | — |
| EPS Growth | 79.4% | 79.4% | 85.5% | -520.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+160.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → -0.00
Residual
+160.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.